Aurobindo Pharma Ltd.

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1986

Chairman: K Ragunathan

Managing Director: N Govindarajan

Group: Aurobindo

Listing: NSE: AUROPHARMA, BSE: 524804

Headquarters: Hyderabad, Telangana

Website: www.aurobindo.com

Market cap: R 43,655.36 Cr

Revenue (TTM): R 22,232.27 Cr

Earnings (TTM): R 2,562.12 Cr

Cash: R 1,957.20 Cr

Total Debt: R 6,966.76 Cr

Promoters' ownership: 52.01%

Liquidity: High

52 Week range: R 288.85 - 750.50

Face value: R1.00

Shares outstanding: 58,59,38,609

10 Years Aggregate:

• CFO: 11,519.39 Cr
• EBITDA: 22,252.06 Cr
• Net Profit: 13,131.42 Cr